Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

Kowarski syndrome

Kowarski syndrome is characterized by bioinactive growth hormone caused by GH1 mutations. Supplementation is effective in these patients.

Systematic

Growth hormone deficiency
GH1
Growth hormone secretagogue resistance
Isolated growth hormone deficiency type 1A
Isolated growth hormone deficiency type 1B
Isolated growth hormone deficiency type 2
Isolated growth hormone deficiency type 3
Kowarski syndrome
GH1

References:

1.

Takahashi Y et al. (1996) Brief report: short stature caused by a mutant growth hormone.

external link
2.

Besson A et al. (2005) Short stature caused by a biologically inactive mutant growth hormone (GH-C53S).

external link
3.

Takahashi Y et al. (1997) Biologically inactive growth hormone caused by an amino acid substitution.

external link
4.

Kowarski AA et al. (1978) Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH.

external link
5.

Valenta LJ et al. (1985) Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers.

external link
6.

Bright GM et al. (1983) Short stature associated with normal growth hormone and decreased somatomedin-C concentrations: response to exogenous growth hormone.

external link
7.

Orphanet article

Orphanet ID 629 external link
8.

OMIM.ORG article

Omim 262650 external link
9.

Wikipedia article

Wikipedia EN (Kowarski_syndrome) external link
Update: Aug. 14, 2020
Copyright © 2005-2024 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues | Website Credits